Glycine, N-[[3-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methoxy]phenyl]methyl]-N-(methoxycarbonyl)-, 100mg

4-Fluorophenylacetylene, 99.0%, 100g

5-(tert-Butyl)-2-hydroxybenzoic acid, 95.0%, 5g

2-(7-hydroxy-2-oxo-2H-chromen-4-yl)acetamide, 95.0%, 1g

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)propan-1-amine, 95%, 250mg

(S)-2,5-Dihydro-1H-pyrrole-2-carboxylic acid hydrochloride, 95.0%, 1g

5-BROMO-4-CHLORO-1H-PYRAZOLO[3,4-B]PYRIDINE, 95%, 10g

Flacon de réaction à bride plate, cylindrique, gradué, avec enveloppe de trempe, pièce de raccordement KF, DN 100, 3000 ml, 190 mm, 1 pièce

3-(2-Bromophenyl)propionic Acid>98.0%(GC)(T)25g

(7-oxaspiro[3.5]nonan-2-yl)methanol, 95.0%, 250mg

6-CHLORO-5-NITRO-1H-INDAZOLE, 95%, 5g

2,6-Dichloro-pyridine-3-sulfonyl chloride, 95.0%, 5g

4-(Piperazin-1-yl)phenol hydrochloride, 98%, 500mg